<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have used a continuous fluorescence monitoring method to assess cyclin D1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in a variety of hematological and non-hematological processes </plain></SENT>
<SENT sid="1" pm="."><plain>We examined 14 cell lines, 11 reactive lymphoid tissues, and 57 primary hematopoietic <z:hpo ids='HP_0002664'>neoplasms</z:hpo> including mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) (n = 10), <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e>) (n = 11), <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 15), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 6), peripheral T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e>) (n = 3), anaplastic large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 3), hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> (n = 3), Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 1), Burkitt-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 4), and <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> (n = 1) for the expression of cyclin D1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> using fluorescently labeled sequence-specific hybridization probes </plain></SENT>
<SENT sid="2" pm="."><plain>Fluorescence (F) was plotted against cycle (C) number over 45 cycles </plain></SENT>
<SENT sid="3" pm="."><plain>The log-linear portion of the F versus C graph identified a fractional cycle number for threshold fluorescence </plain></SENT>
<SENT sid="4" pm="."><plain>A beta-<z:chebi fb="0" ids="5386">globin</z:chebi> <z:chebi fb="2" ids="33699">mRNA</z:chebi> transcript with equivalent amplification efficiency to that of cyclin D1 was used for assessment of <z:chebi fb="40" ids="33697">RNA</z:chebi> integrity and normalization </plain></SENT>
<SENT sid="5" pm="."><plain>In general, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e> demonstrated substantially higher levels of cyclin D1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> than the other lymphoproliferative processes </plain></SENT>
<SENT sid="6" pm="."><plain>Moderately high levels of cyclin D1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> were detected in one <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>On average, the <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e> cases showed cyclin D1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels two to three orders of magnitude lower than observed in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Cell lines derived from non-hematopoietic <z:hpo ids='HP_0002664'>neoplasms</z:hpo> such as <z:hpo ids='HP_0100244'>fibrosarcoma</z:hpo>, small cell <z:mp ids='MP_0002038'>carcinoma</z:mp>, and <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> showed comparable or higher levels of cyclin D1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> than the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCLs</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Our results indicate that quantitative real-time reverse transcription (RT) polymerase chain reaction is a simple, rapid, and accurate technique for assessing cyclin D1 expression, and while it is not specific, it can reliably be used in the distinction of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> from <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e> </plain></SENT>
</text></document>